Updated Results of a Prospective Study: Rituximab and Lenalidomide Plus Chidamide (RLC) for Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma Cong Li,Huixian HU,Tao Lei,Haifeng Yu,Xi Chen,Shuailing Peng,Shuiyun Han,Haiyan YangBlood(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要